These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6247259)

  • 21. Hypertensive crisis in systemic sclerosis: treatment with the new oral angiotensin converting enzyme inhibitor MK, 421 (Enalapril) in captopril-intolerant patients.
    Smith CD; Smith RD; Korn JH
    Arthritis Rheum; 1984 Jul; 27(7):826-8. PubMed ID: 6331462
    [No Abstract]   [Full Text] [Related]  

  • 22. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
    Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)].
    Rahn KH; Stumpe KO
    MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S5-14. PubMed ID: 6323979
    [No Abstract]   [Full Text] [Related]  

  • 25. [Successful treatment of severe refractory hypertension with captopril].
    Gabizon D; Weissgarten Y; Pik A; Modai D
    Harefuah; 1981 Oct; 101(7-8):167-9. PubMed ID: 6277749
    [No Abstract]   [Full Text] [Related]  

  • 26. Captopril: an oral angiotension converting enzyme inhibitor active in man.
    Brunner HR; Gavras H; Waeber B; Turini GA; Wauters JP
    Arch Int Pharmacodyn Ther; 1980; Suppl():188-212. PubMed ID: 6251762
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of refractory arterial hypertension with a converting enzyme inhibiting drug (Captopril)].
    Lavezzaro GC; Angelino PF; Gastaldo D; Minelli M; Paccotti P; Angeli A
    Minerva Cardioangiol; 1981 Oct; 29(10):519-25. PubMed ID: 7033830
    [No Abstract]   [Full Text] [Related]  

  • 28. [Usefulness of combined captopril-labetalol treatment in resistant hypertension (author's transl)].
    El Matri A; Larabi MS; Kheder A; Belkahia C; Kechrid C; Ben Maiz H; Ben Ayed H
    Nouv Presse Med; 1982 May; 11(21):1611-3. PubMed ID: 7048251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension.
    Zweifler AJ; Julius S; Nicholls MG
    Arch Intern Med; 1981 Jun; 141(7):907-10. PubMed ID: 6263204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with the angiotensin converting enzyme inhibitor captopril.
    Walter NM; Whitworth JA; Kincaid-Smith P
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():117-21. PubMed ID: 6291829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the oral angiotensin I--converting enzyme inhibitor (captopril) in childhood malignant hypertension.
    Oberfield SE; Case DB; Levine LS; Rapaport R; Rauh W; New MI
    J Pediatr; 1979 Oct; 95(4):641-4. PubMed ID: 383935
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of angiotensin-converting enzyme: therapeutic implications.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Isr J Med Sci; 1982 Oct; 18(10):981-5. PubMed ID: 6293997
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term converting enzyme inhibition versus surgical treatment in hypertensive patients with renovascular disease.
    Staessen J; Bulpitt CJ; Fagard R; Lijnen P; Amery A
    Neth J Med; 1984; 27(4):161-4. PubMed ID: 6330590
    [No Abstract]   [Full Text] [Related]  

  • 34. SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme.
    Rubin B; Laffan RJ; Kotler DG; O'Keefe EH; Demaio DA; Goldberg ME
    J Pharmacol Exp Ther; 1978 Feb; 204(2):271-80. PubMed ID: 202692
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of angiotensin I to II converting enzyme inhibitor S.Q. 14225 (captopril), in moderate essential hypertension.
    Ryan E; Muldowney FP
    Ir Med J; 1983 Apr; 76(4):175, 177-8. PubMed ID: 6345457
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)].
    Morimoto Y; Baba M; Takahashi T; Fujii M; Konishi T; Kawanami C; Hamada M; Nakano T; Takezawa H
    Kokyu To Junkan; 1982 Mar; 30(3):317-25. PubMed ID: 6808624
    [No Abstract]   [Full Text] [Related]  

  • 37. Malignant hypertension in a child with hemolytic-uremic syndrome treated with captopril.
    Monnens L; Drayer J; De Jong M
    Acta Paediatr Scand; 1981 Jul; 70(4):583-5. PubMed ID: 7032189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Malignant arterial hypertension in scleroderma. Beneficial effects of captopril on pulmonary and systemic vascular resistance].
    Bonnet F; Matamis D; Lepresle E; Cabane J; Le Gall JR
    Nouv Presse Med; 1982 May; 11(20):1570-1. PubMed ID: 7048249
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
    Waeber B; Brunner HR; Wauters JP; Gavras H
    Adv Nephrol Necker Hosp; 1981; 10():111-33. PubMed ID: 6267906
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes in angiotensinogen and des-angiotensin I-angiotensinogen in man and rat upon inhibition of converting enzyme].
    Clauser E; Genain C; Bouhnik J; Corvol P; Ménard J
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():157-61. PubMed ID: 6287956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.